CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) |
3 Months Ended | 6 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|||||
| OPERATING EXPENSES | ||||||||
| RESEARCH AND DEVELOPMENT EXPENSES | $ 57,352 | $ 238,612 | $ 275,548 | $ 656,819 | ||||
| Selling, general and administrative expense | [1] | 16,372,883 | 1,015,733 | 27,821,947 | 2,805,048 | |||
| Total operating expenses | 16,430,235 | 1,254,345 | 28,097,495 | 3,461,867 | ||||
| OPERATING LOSS | (16,430,235) | (1,254,345) | (28,097,495) | (3,461,867) | ||||
| OTHER INCOME (EXPENSE), NET | ||||||||
| Interest income | 14,581 | 1,409 | 25,884 | 3,940 | ||||
| Interest expense | (219,583) | (275,665) | (233,750) | (1,649,710) | ||||
| Change in fair value of digital assets | (9,705,974) | 0 | (29,710,439) | 0 | ||||
| Other derivative income, net | 671,391 | 0 | 2,228,110 | 0 | ||||
| Provision for credit losses | (354,446) | 0 | (2,531,270) | 0 | ||||
| Total other expense, net | (9,594,031) | (274,256) | (30,221,465) | (1,645,770) | ||||
| LOSS BEFORE INCOME TAXES | (26,024,266) | (1,528,601) | (58,318,960) | (5,107,637) | ||||
| Income tax benefit | (5,235,692) | 0 | (11,975,617) | 0 | ||||
| NET LOSS | (20,788,574) | (1,528,601) | (46,343,343) | (5,107,637) | ||||
| Deemed dividends on Series C, D and H preferred stock | 0 | (2,158,161) | 0 | (2,181,823) | ||||
| Net loss attributable to common stockholders, basic | (20,788,574) | (3,686,762) | (46,343,343) | (7,289,460) | ||||
| Net loss attributable to common stockholders, diluted | $ (20,788,574) | $ (3,686,762) | $ (46,343,343) | $ (7,289,460) | ||||
| Basic loss per share (in dollars per share) | $ (0.05) | $ (0.55) | $ (0.12) | $ (1.52) | ||||
| Diluted loss per share (in dollars per share) | $ (0.05) | $ (0.55) | $ (0.12) | $ (1.52) | ||||
| Weighted average shares of common stock outstanding- basic (in shares) | [2] | 388,144,429 | 6,672,777 | 388,144,334 | 4,780,564 | |||
| Weighted average shares of common stock outstanding- diluted (in shares) | [2] | 388,144,429 | 6,672,777 | 388,144,334 | 4,780,564 | |||
| ||||||||
| X | ||||||||||
- Definition Amount of unrealized gain (loss) from remeasurement of crypto asset, classified as nonoperating. Excludes crypto asset held for platform user. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of expense related loan transactions, lease transactions, credit loss from transactions other than loan and lease transactions, and other loss based on assessment of uncollectability from the counterparty to reduce the account to their net realizable value. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|